Search

for
Search:

Did you mean glucagon-like peptide-1 receptor agonists?

GlossaryGLP-1 receptor agonists

mimic a hormone to regulate blood sugar and promote fullness

GLP-1 receptor agonists are a class of medications that mimic the action of the glucagon-like peptide-1 (GLP-1) hormone, which helps regulate blood sugar levels by enhancing insulin secretion and inhibiting glucagon release. They are commonly used in the treatment of type 2 diabetes and can also promote weight loss by slowing gastric emptying and increasing feelings of fullness.

Related Terms

Learn

0 / 0 results

— no results

Research

5 / 311 results

research Editor's Highlights: September 2024

August 2024 in “International Journal of Dermatology”

New therapies and treatments for hair disorders, especially in curly hair, show promise.

research A Review of Metabolic Dysregulation in Lymphocytic Cicatricial Alopecia: Exploring the Connections and Therapeutic Implications

1 citations , March 2025 in “Journal of Investigative Dermatology”

Metabolic issues may trigger lymphocytic cicatricial alopecia, and treatments targeting these issues could help.

research Current Possible Treatment Approaches of Polycystic Ovary Syndrome (PCOS)

February 2024 in “Journal of Education, Health and Sport”

Different treatments for PCOS should be tailored to the individual, including lifestyle changes and various medications.

research Polycystic Ovarian Disease: Current Insights and Therapeutic Strategies

December 2024 in “African Journal of Biomedical Research”

Combining lifestyle changes and medication is most effective for managing PCOS symptoms.

research Editorial: Exploring Innovative Therapies for Rare Inflammatory Skin Diseases

March 2026 in “Frontiers in Medicine”

The editorial highlights recent advancements in therapies for rare inflammatory skin diseases, focusing on mechanism-based interventions like biologics and small molecules. It discusses the approval of targeted treatments for conditions such as psoriasis and atopic dermatitis, while noting challenges in developing therapies for rare dermatoses. Innovative approaches, such as JAK inhibitors for alopecia areata and palmoplantar pustulosis, and GLP-1 agonists for obesity-related skin conditions, are explored. The importance of patient involvement in treatment decisions, particularly for hidradenitis suppurativa, is emphasized. The editorial also presents new molecular classifications to aid in diagnosis and treatment. It concludes by stressing the need for further research and clinical trials to confirm the efficacy and safety of these emerging therapies.

View more "glucagon-like peptide-1 agonists" in research →

Community Join

3 / 3 results

community Any treatments in development that could theoretically give complete regrowth?

in Research/Science 8 upvotes 10 months ago

New hair loss treatments like PP-405, AMP-303, and SCUBE3 are being discussed, but none are confirmed to fully restore hairlines. Current treatments like Minoxidil, Finasteride, and RU58841 are still widely used, with some hope for future advancements in hair regrowth.

community Will Pp405 be the Ozempic of bald Guys

in Research/Science 102 upvotes 1 month ago

PP405 is being discussed as a potential hair loss treatment, possibly more effective than minoxidil. There are concerns about its effectiveness and product contamination, but some users report early signs of hair regrowth.

community Gyno & testoterone level

Warta_B in Finasteride 282 upvotes 1 year ago

Switching from finasteride to dutasteride and back to finasteride led to gynecomastia and fatigue, likely due to hormonal imbalances. Suggested treatments include Tamoxifen, Raloxifene, or low-dose Anastrozole, with a recommendation to test testosterone and estradiol levels.